Inter- and Intra-Observer Agreement of PD-L1 SP142 Scoring in Breast Carcinoma—A Large Multi-Institutional International Study

SIMPLE SUMMARY: PD-L1 analysis in TNBC is essential for selecting patients eligible for immunotherapy. Limited data are available on pathologists’ concordance regarding PD-L1 assessment. Twelve pathologists of various expertise from three European countries digitally analysed 100 breast cancer core...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaakouk, Mohamed, Van Bockstal, Mieke, Galant, Christine, Callagy, Grace, Provenzano, Elena, Hunt, Roger, D’Arrigo, Corrado, Badr, Nahla M., O’Sullivan, Brendan, Starczynski, Jane, Tanchel, Bruce, Mir, Yasmeen, Lewis, Paul, Shaaban, Abeer M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000421/
https://www.ncbi.nlm.nih.gov/pubmed/36900303
http://dx.doi.org/10.3390/cancers15051511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000421/
https://www.ncbi.nlm.nih.gov/pubmed/36900303
http://dx.doi.org/10.3390/cancers15051511

Ejemplares similares